Junyuan Jerry Wang

Dr. Junyuan (Jerry) Wang is Chief Executive Officer & Co-Founder at AnHeart Therapeutics. He has more than 20 years of leadership experience in global clinical development and medical research, having previously worked at Merck Serono, BMS, Wyeth/Pfizer, The Medicines Company, and Merck & Co. He has broad drug development experience across multiple therapeutic areas including oncology, cardiovascular, neuroscience, and immunology. He has made key contributions to the successful NDA of Bosulif and Eliquis, and the latter became a multi-billion blockbuster drug. He has extensive experience with global health authorities including FDA, EMA, PMDA, and NMPA. He also served in leadership roles for professional societies and on the programming committee of leading scientific conferences. Dr. Wang earned his B.S. from the University of Science and Technology of China and his Ph.D. in Statistics from the Iowa State of University.